Intelligent Investors Den!
Sign up Now and Gain Access to Exciting Opportunities from Investor and Resource Space!
By submitting your details and clicking on the SIGN UP button you agree to Kalkine’s Free Trial-Terms of Use and consent to receive marketing offers including to be contacted by email or phone, as set out in our Privacy Policy Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf. You also agree that Kalkine/KSPL can give you its Financial Services Guide by electronic means (including by website link or email). Before accessing our services, please read the Financial Services Guide available here.
By creating account you will get access to hot stocks & personalised emails
Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf.
Last update at 2025-01-23T05:10:00Z
Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
Mesoblast (ASX:MSB) investors are sitting on a loss of 88% if they invested three years ago
Mesoblast Limited (MESO) Loses -5.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
5 Stocks to Ride the Santa Claus Rally
Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug
Most Shareholders Will Probably Find That The Compensation For Mesoblast Limited's (ASX:MSB) CEO Is Reasonable
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?